|
1
|
Li W, Zhang H, Assaraf YG, Zhao K, Xu X,
Xie J, Yang DH and Chen ZS: Overcoming ABC transporter-mediated
multidrug resistance: Molecular mechanisms and novel therapeutic
drug strategies. Drug Resist Updat. 27:14–29. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhang K, Mack P and Wong KP:
Glutathione-related mechanisms in cellular resistance to anticancer
drugs. Int J Oncol. 12:871–882. 1998.PubMed/NCBI
|
|
3
|
Dean M, Hamon Y and Chimini G: The human
ATP-binding cassette (ABC) transporter superfamily. J Lipid Res.
42:1007–1017. 2001.PubMed/NCBI
|
|
4
|
Tiwari AK, Sodani K, Dai CL, Ashby CR Jr
and Chen ZS: Revisiting the ABCs of multidrug resistance in cancer
chemotherapy. Curr Pharm Biotechnol. 12:570–594. 2011. View Article : Google Scholar
|
|
5
|
Gottesman MM, Fojo T and Bates SE:
Multidrug resistance in cancer: Role of ATP-dependent transporters.
Nat Rev Cancer. 2:48–58. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sarkadi B, Homolya L, Szakács G and Váradi
A: Human multidrug resistance ABCB and ABCG transporters:
Participation in a chemoimmunity defense system. Physiol Rev.
86:1179–1236. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Szakács G, Paterson JK, Ludwig JA,
Booth-Genthe C and Gottesman MM: Targeting multidrug resistance in
cancer. Nat Rev Drug Discov. 5:219–234. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ambudkar SV, Dey S, Hrycyna CA,
Ramachandra M, Pastan I and Gottesman MM: Biochemical, cellular,
and pharmacological aspects of the multidrug transporter. Annu Rev
Pharmacol Toxicol. 39:361–398. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yanagisawa T, Newman A, Coley H, Renshaw
J, Pinkerton CR and Pritchard-Jones K: BIRICODAR (VX-710; Incel):
An effective chemosensitizer in neuroblastoma. Br J Cancer.
80:1190–1196. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rowinsky EK, Smith L, Wang YM, Chaturvedi
P, Villalona M, Campbell E, Aylesworth C, Eckhardt SG, Hammond L,
Kraynak M, et al: Phase I and pharmacokinetic study of paclitaxel
in combination with biricodar, a novel agent that reverses
multidrug resistance conferred by overexpression of both MDR1 and
MRP. J Clin Oncol. 16:2964–2976. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Leonard GD, Fojo T and Bates SE: The role
of ABC transporters in clinical practice. Oncologist. 8:411–424.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Leonard GD, Polgar O and Bates SE: ABC
transporters and inhibitors: New targets, new agents. Curr Opin
Investig Drugs. 3:1652–1659. 2002.PubMed/NCBI
|
|
13
|
Cui Y: Advances in study on chemical
compositions and pharmacological activities of Uncaria
rhynchophylla. J Xi'an Univ Natural Science Edition). 18:16–18.
2015.In Chinese.
|
|
14
|
He Y: Pharmacological development of
ramulus Uncariae cum uncis and its active ingredients. Shanghai
Univ Tradit Chin Med. 37:57–60. 2003.In Chinese.
|
|
15
|
Ndagijimana A, Wang X, Pan G, Zhang F,
Feng H and Olaleye O: A review on indole alkaloids isolated from
Uncaria rhynchophylla and their pharmacological studies.
Fitoterapia. 86:35–47. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu DL, Li YJ, Yao N, Xu J, Chen ZS, Yiu
A, Zhang CX, Ye WC and Zhang DM: Acerinol, a cyclolanstane
triterpenoid from Cimicifuga acerina, reverses ABCB1-mediated
multidrug resistance in HepG2/ADM and MCF-7/ADR cells. Eur J
Pharmacol. 733:34–44. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang J, Yang CJ and Wu DG: Studies on the
chemical constituents of sharpleaf gambir plant (Uncaria
rhynchophylla) (II). Chin Tradit Herbal Drugs. 29:649–651.
1998.
|
|
18
|
Yamanaka E, Kimizuka Y, Aimi N, Sakai S
and Haginiwa J: Studies of plants containing indole alkaloids. IX.
Quantitative analysis of tertiary alkaloids in various parts of
Uncaria rhynchophylla MIQ. Yakugaku Zasshi. 103:1028–1033. 1983.In
Japanese. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
He SM, Li R, Kanwar JR and Zhou SF:
Structural and functional properties of human multidrug resistance
protein 1 (MRP1/ABCC1). Curr Med Chem. 18:439–481. 2011. View Article : Google Scholar
|
|
20
|
Krishnamurthy P and Schuetz JD: The role
of ABCG2 and ABCB6 in porphyrin metabolism and cell survival. Curr
Pharm Biotechnol. 12:647–655. 2011. View Article : Google Scholar
|
|
21
|
Ye L, Lu L, Li Y, Zeng S, Yang X, Chen W,
Feng Q, Liu W, Tang L and Liu Z: Potential role of ATP-binding
cassette transporters in the intestinal transport of rhein. Food
Chem Toxicol. 58:301–305. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Babu K, Zhang J, Moloney S, Pleasants T,
McLean CA, Phua SH and Sheppard AM: Epigenetic regulation of ABCG2
gene is associated with susceptibility to xenobiotic exposure. J
Proteomics. 75:3410–3418. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kummu M, Sieppi E, Wallin K, Rautio A,
Vähäkangas K and Myllynen P: Cadmium inhibits ABCG2 transporter
function in BeWo choriocarcinoma cells and MCF-7 cells
overexpressing ABCG2. Placenta. 33:859–865. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tang SJ, Chen LK, Wang F, Zhang YK, Huang
ZC, To KK, Wang XK, Talele TT, Chen ZS, Chen WQ, et al: CEP-33779
antagonizes ATP-binding cassette subfamily B member 1 mediated
multidrug resistance by inhibiting its transport function. Biochem
Pharmacol. 91:144–156. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Aller SG, Yu J, Ward A, Weng Y,
Chittaboina S, Zhuo R, Harrell PM, Trinh YT, Zhang Q, Urbatsch IL,
et al: Structure of P-glycoprotein reveals a molecular basis for
poly-specific drug binding. Science. 323:1718–1722. 2009.
View Article : Google Scholar : PubMed/NCBI
|
